Lausanne, Switzerland (PRWEB) December 12, 2012
Crisalix, amongst “the best-of-the-best at the 2012 European Venture Contest” [Europe Unlimited]
The European Venture Contest (EVC) held in Berlin is the largest meeting point for innovative entrepreneurs in the Information & Communications Technology (ICT), Life Sciences and Cleantech sectors. The EVC plays an important role in finding, evaluating and recognizing world-class innovative companies to accelerate their growth by providing access to top-level international partners, and supporting these global leaders of tomorrow by updating the skill set needed to grow their business successfully.
The EVC brings together over 300 top tier venture investors as well as corporate investors from multinationals such as IBM, Roche, Microsoft, Philips, SAP and more. Through 10 rounds of presentations and shortlisting which took place over one year across the main European countries, from an initial 800+ companies the jury made a final selection of the top 10 companies which included Crisalix as one of the only three Life Science companies offering novel technologies, products and services that are expected to dramatically impact their respective industry over the coming years.
This award from top international investors based on specific criteria related to business potential, product merit, competitive positioning and project profile quality amongst others, confirms Crisalix’s position as a leader and pioneer in the field of Aesthetics. It is recognition for the potential that Crisalix represents today and for the years ahead.
If you were considering modifying your physical appearance, wouldn’t you be wondering “how could I look after the procedure?” Crisalix is a worldwide leader in easy 3D aesthetic simulations based on standard digital photo
Copyright©2012 Vocus, Inc.
All rights reserved